260 related articles for article (PubMed ID: 27368058)
1. Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis.
Cao J; Zhu X; Zhao X; Li XF; Xu R
PLoS One; 2016; 11(7):e0158770. PubMed ID: 27368058
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
Tang L; Li X; Wang B; Luo G; Gu L; Chen L; Liu K; Gao Y; Zhang X
PLoS One; 2016; 11(4):e0153981. PubMed ID: 27096158
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer: A Systematic Review and Meta-analysis.
Yin X; Xiao Y; Li F; Qi S; Yin Z; Gao J
Medicine (Baltimore); 2016 Jan; 95(3):e2544. PubMed ID: 26817900
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients.
Gu X; Gao X; Li X; Qi X; Ma M; Qin S; Yu H; Sun S; Zhou D; Wang W
Sci Rep; 2016 Feb; 6():22089. PubMed ID: 26912340
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral Corticosteroids.
Mehra N; Sharp A; Lorente D; Dolling D; Sumanasuriya S; Johnson B; Dearnaley D; Parker C; de Bono J
Clin Genitourin Cancer; 2017 Dec; 15(6):678-684.e1. PubMed ID: 28606735
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
Lu Y; Jiang J; Ren C
PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-Analysis.
Luo Y; She DL; Xiong H; Fu SJ; Yang L
Medicine (Baltimore); 2015 Oct; 94(40):e1670. PubMed ID: 26448011
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies.
Wu S; Zhao X; Wang Y; Zhong Z; Zhang L; Cao J; Ai K; Xu R
Cell Physiol Biochem; 2018; 46(4):1352-1364. PubMed ID: 29689562
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
Peng H; Luo X
Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
[TBL] [Abstract][Full Text] [Related]
12. Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients.
Vartolomei MD; Kimura S; Ferro M; Vartolomei L; Foerster B; Abufaraj M; Shariat SF
World J Urol; 2018 Jul; 36(7):1019-1029. PubMed ID: 29468284
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.
Kwon YS; Han CS; Yu JW; Kim S; Modi P; Davis R; Park JH; Lee P; Ha YS; Kim WJ; Kim IY
Clin Genitourin Cancer; 2016 Feb; 14(1):e1-8. PubMed ID: 26341038
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.
Buttigliero C; Pisano C; Tucci M; Vignani F; Bertaglia V; Iaconis D; Guglielmini P; Numico G; Scagliotti GV; Di Maio M
Acta Oncol; 2017 Apr; 56(4):555-562. PubMed ID: 28068151
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.
Chen J; Deng Q; Pan Y; He B; Ying H; Sun H; Liu X; Wang S
FEBS Open Bio; 2015; 5():502-7. PubMed ID: 26137435
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer: A Systematic Review and Meta-Analysis of Observational Studies.
Huang QT; Zhou L; Zeng WJ; Ma QQ; Wang W; Zhong M; Yu YH
Cell Physiol Biochem; 2017; 41(6):2411-2418. PubMed ID: 28467978
[TBL] [Abstract][Full Text] [Related]
17. High preoperative neutrophil-lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy.
Lee H; Jeong SJ; Hong SK; Byun SS; Lee SE; Oh JJ
World J Urol; 2016 Jun; 34(6):821-7. PubMed ID: 26449784
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.
Cheng H; Long F; Jaiswar M; Yang L; Wang C; Zhou Z
Sci Rep; 2015 Jul; 5():11026. PubMed ID: 26226887
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis.
Wang Z; Peng S; Xie H; Guo L; Jiang N; Shang Z; Niu Y
Cancer Manag Res; 2018; 10():3599-3610. PubMed ID: 30271208
[TBL] [Abstract][Full Text] [Related]
20. The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis.
Xu ZG; Ye CJ; Liu LX; Wu G; Zhao ZX; Wang YZ; Shi BQ; Wang YH
Biomark Med; 2018 Feb; 12(2):189-199. PubMed ID: 29327595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]